Literature DB >> 17182696

Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN.

Cesar Boggiano1, Nicolas Manel, Dan R Littman.   

Abstract

Dendritic cells (DCs) enhance human immunodeficiency virus type 1 (HIV-1) infection of CD4(+) T lymphocytes in trans. The C-type lectin DC-SIGN, expressed on DCs, binds to the HIV-1 envelope glycoprotein gp120 and confers upon some cell lines the capacity to enhance trans-infection. Using a short hairpin RNA approach, we demonstrate that DC-SIGN is not required for efficient trans-enhancement by DCs. In addition, the DC-SIGN ligand mannan and an anti-DC-SIGN antibody did not inhibit DC-mediated enhancement. HIV-1 particles were internalized and were protected from protease treatment following binding to DCs, but not from binding to DC-SIGN-expressing Raji cells. Thus, DC-SIGN is not required for DC-mediated trans-enhancement of HIV infectivity.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17182696      PMCID： PMC1865951          DOI： 10.1128/JVI.01661-06

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  22 in total

1.  Recruitment of HIV and its receptors to dendritic cell-T cell junctions.

Authors:  David McDonald; Li Wu; Stacy M Bohks; Vineet N KewalRamani; Derya Unutmaz; Thomas J Hope
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

2.  Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.

Authors:  Stuart G Turville; John J Santos; Ines Frank; Paul U Cameron; John Wilkinson; Monica Miranda-Saksena; Joanne Dable; Hella Stössel; Nikolaus Romani; Michael Piatak; Jeffrey D Lifson; Melissa Pope; Anthony L Cunningham
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

3.  Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission.

Authors:  Li Wu; Thomas D Martin; Mary Carrington; Vineet N KewalRamani
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

4.  cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor.

Authors:  B Lee; G Leslie; E Soilleux; U O'Doherty; S Baik; E Levroney; K Flummerfelt; W Swiggard; N Coleman; M Malim; R W Doms
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection.

Authors:  Douglas S Kwon; Glenn Gregorio; Natacha Bitton; Wayne A Hendrickson; Dan R Littman
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

6.  Lentivirus-delivered stable gene silencing by RNAi in primary cells.

Authors:  Sheila A Stewart; Derek M Dykxhoorn; Deborah Palliser; Hana Mizuno; Evan Y Yu; Dong Sung An; David M Sabatini; Irvin S Y Chen; William C Hahn; Phillip A Sharp; Robert A Weinberg; Carl D Novina
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

7.  Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.

Authors:  Jean-François Arrighi; Marjorie Pion; Maciej Wiznerowicz; Teunis B Geijtenbeek; Eduardo Garcia; Shahnaz Abraham; Florence Leuba; Valérie Dutoit; Odile Ducrey-Rundquist; Yvette van Kooyk; Didier Trono; Vincent Piguet
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway.

Authors:  Suryaram Gummuluru; Mark Rogel; Leonidas Stamatatos; Michael Emerman
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

Review 10.  After Hrs with HIV.

Authors:  Ali Amara; Dan R Littman
Journal:  J Cell Biol       Date:  2003-08-04       Impact factor: 10.539
View more
  51 in total

Review 1.  Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Authors:  S Phogat; R T Wyatt; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

2.  Biology of HIV mucosal transmission.

Authors:  Li Wu
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

Review 3.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

4.  Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells.

Authors:  Morgan A Reuter; Nicole D Pecora; Clifford V Harding; David H Canaday; David McDonald
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 5.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 6.  HIV infection of the genital mucosa in women.

Authors:  Florian Hladik; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

7.  SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission.

Authors:  Theresa L Chang; Natalia Teleshova; Aprille Rapista; Maciej Paluch; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Angela Granelli-Piperno; Mary E Klotman
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124

8.  Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.

Authors:  Chawaree Chaipan; Imke Steffen; Theodros Solomon Tsegaye; Stephanie Bertram; Ilona Glowacka; Yukinari Kato; Jan Schmökel; Jan Münch; Graham Simmons; Rita Gerardy-Schahn; Stefan Pöhlmann
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

Review 9.  HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?

Authors:  Nuria Izquierdo-Useros; Mar Naranjo-Gómez; Itziar Erkizia; Maria Carmen Puertas; Francesc E Borràs; Julià Blanco; Javier Martinez-Picado
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

Review 10.  HIV transmission.

Authors:  George M Shaw; Eric Hunter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.